SMRD 2025
The second Symposium on Molecular Radiotherapy Dosimetry (SMRD), subtitled
“The Future of Theragnostics”, was organized by the EFOMP Special Interest Group on Radionuclide Internal Dosimetry and hosted by the Hellenic Association of Medical Physics in Athens, Greece, in mid-November 2025.
Monika and Caroline contributed to the scientific programme with an oral presentation on tumour-to-kidney absorbed dose ratios for DOTATATE therapies, with particular relevance for potential alpha-emitting radionuclides. Caroline also presented updates from the EANM. In addition, a presentation of a dosimetry software tender document, of which Caroline has contributed, was given during the meeting.
Slides from the invited talks, as well as the abstract book, have been published online. Direct links to abstracts involving contributions from our group can be found here and here.